Clinical trials for the treatment of Coronavirus disease 2019 (COVID-19): A rapid response to urgent need

Affiliations

¹ Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
² Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
³ Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, College of Medicine, Xiamen University, Xiamen, 361003, China.
⁴ Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China. xukf@pumch.cn.

Tengyue Zhang et al. Sci China Life Sci. 2020 May.

. 2020 May;63(5):774-776.

doi: 10.1007/s11427-020-1660-2. Epub 2020 Feb 29.

¹ Department of Internal Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
² Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China.
³ Department of Pulmonary and Critical Care Medicine, The First Affiliated Hospital, College of Medicine, Xiamen University, Xiamen, 361003, China.
⁴ Department of Pulmonary and Critical Care Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, 100730, China. xukf@pumch.cn.

No abstract available

Conflict of interest statement

Compliance and ethics The author(s) declare that they have no conflict of interest.

1. Chan KS, Lai ST, Chu CM, Tsui E, Tarn CY, Wong MM, Tse M W, Que TL, Peiris JS, Sung J, et al. Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J. 2003;9:399–406. - PubMed
1. Chen Y, Guo JJ, Healy DP, Zhan S. Effect of integrated traditional Chinese medicine and western medicine on the treatment of severe acute respiratory syndrome: A meta-analysis. Pharmacy pract (Granada Ed impr) 2007;5:1–9. - PMC - PubMed
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, et al. Clinical features of patients infected with 2019 novel Coronavirus in Wuhan, China. Lancet. 2020;395:497–506. doi: 10.1016/S0140-6736(20)30183-5. - DOI - PMC - PubMed
1. Maxmen A. More than 80 clinical trials launch to test Coronavirus treatments. Nature. 2020;578:347–348. doi: 10.1038/d41586-020-00444-3. - DOI - PubMed
1. Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M, Shi Z, Hu Z, Zhong W, Xiao G. Cell Res. 2020. Remdesivir and chloroquine effectively inhibit the recently emerged novel Coronavirus (2019-nCoV) in vitro. - PMC - PubMed